12x6Gy-the Erlangen stereotactic radiotherapy treatment concept result in 95% local progression-free survival for bronchial carcinoma and 83% for pulmonary metastases after 3 years

Lubgan D, Rutzner S, Lambrecht U, Fietkau R (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 41

Pages Range: 148-148

Authors with CRIS profile

Dorota Lubgan Department of Radiation Oncology Sandra Rutzner Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie

How to cite

APA:

Lubgan, D., Rutzner, S., Lambrecht, U., & Fietkau, R. (2018). 12x6Gy-the Erlangen stereotactic radiotherapy treatment concept result in 95% local progression-free survival for bronchial carcinoma and 83% for pulmonary metastases after 3 years. (pp. 148-148).

MLA:

Lubgan, Dorota, et al. "12x6Gy-the Erlangen stereotactic radiotherapy treatment concept result in 95% local progression-free survival for bronchial carcinoma and 83% for pulmonary metastases after 3 years." 2018. 148-148.

BibTeX: Download